Health Care & Life Sciences » Pharmaceuticals | Seoul Pharma Co. Ltd.

Seoul Pharma Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
42,043
43,816
44,731
45,920
46,652
Cost of Goods Sold (COGS) incl. D&A
18,032
19,098
22,454
20,049
18,178
Gross Income
24,011
24,718
22,277
25,870
28,474
SG&A Expense
22,676
24,040
21,602
22,897
24,354
EBIT
1,335
677
675
2,973
4,120
Unusual Expense
35
-
5
449
2,018
Non Operating Income/Expense
552
58
704
39
1
Interest Expense
386
214
1,050
2,229
1,899
Pretax Income
429
525
977
496
338
Income Tax
189
1,220
194
320
543
Consolidated Net Income
618
696
783
817
881
Net Income
618
696
783
817
881
Net Income After Extraordinaries
618
696
783
817
881
Net Income Available to Common
618
696
783
817
881
EPS (Basic)
93.00
101.00
111.00
112.00
111.00
Basic Shares Outstanding
7
7
7
7
8
EPS (Diluted)
93.07
101.49
111.33
112.34
111.47
Diluted Shares Outstanding
7
7
7
7
8
EBITDA
3,815
3,154
4,461
5,956
6,657
Non-Operating Interest Income
67
3
106
162
135

About Seoul Pharma Co.

View Profile
Address
124-31 Osongsaengmyeong 6-ro
Cheongju NC 28158
Korea, Republic Of
Employees -
Website http://www.seoulpharma.com
Updated 09/14/2018
Seoul Pharma Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. Its products include drugs for cardiovascular system, respiratory and digestive system, antipyretic, analgesic, anti-inflammatory, antibacterial, anti-fungal, anti-viral, cream and ointment, anti-diabetic, anti-obesity, tonics, vitamins and minerals. The company was founded in 1976 and is headquartered in Cheongju, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.